When analyzing the tumor infiltrating Mam-A specific CD8 T cells 7 days post transfer, mice that had received splenocytes from Mam-A2.2 and Mam-A2.4 vaccinated mice were found to have a larger number of Mam-A specific tetramer+ CD8 T cells compared to Mam-A2.1, Mam-A2.6 and full-length vaccinated mice (Fig. 1f). Here, CD8A is linked to neoplasm.